CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy CEO bought 5,000 shares at $5.50 ($27,500)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · New debt or obligation
- 10-K/A Report 10-K/A
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes Principal Accounting Officer gave up 669 shares (to pay taxes)
- 4 Shares withheld for taxes President & CMO gave up 609 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 1,827 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Chairman gave up 2,250 shares (to pay taxes)
Page 11 of 68 · 1,358 filings